Benchmark Reiterates Buy Rating on Bio-Techne Corp. (TECH)

February 3, 2026 9:24 AM EST Send to a Friend
Benchmark analyst Robert Wasserman reiterated a Buy rating and $75.00 price target on Bio-Techne Corp. (NASDAQ: TECH).The analyst commented, "Bio-Techne ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login